SynapDx

company

About

SynapDX is an early-stage laboratory services company developing blood-based diagnostic tests for the early detection of autism.

  • 11 - 50

Details

Last Funding Type
Series C
Last Funding Money Raised
$2M
Industries
Health Care,Health Diagnostics,Medical Device
Founded date
Jan 1, 2010
Number Of Employee
11 - 50
Operating Status
Active

SynapDx's mission is to provide laboratory testing services to physicians who evaluate children for developmental disorders with the initial goal of enabling earlier detection of autism.

Autism Spectrum Disorders are currently estimated to affect 1 in 110 children in the United States according to the Centers for Disease Control.

SynapDx was founded by Stanley Lapidus and closed a Series A round of venture funding in May 2010 from North Bridge Venture Partners, Bain Capital Ventures, and General Catalyst Partners.

SynapDx's corporate headquarters is located in Lexington, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
4
$32.40M
SynapDx has raised a total of $32.40M in funding over 2 rounds. Their latest funding was raised on Jul 22, 2013 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 22, 2013 Series Unknown $15.40M 1 Detail
Feb 21, 2013 Series C $2M 1 LabCorp Detail
Nov 12, 2012 Series B $6M 1 Detail
Jun 1, 2010 Series A $9M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
SynapDx is funded by 2 investors. LabCorp and General Catalyst are the most recent investors.
Investor Name Lead Investor Funding Round
LabCorp Series Unknown
General Catalyst Series B